HealthLeap key facts
as of Feb 2026- Developer of an artificial intelligence-driven clinical decision support platform designed for patient risk identification and malnutrition management.
- HealthLeap is valued at approximately $205.5M as of Feb 2026 (last reported valuation).
- It has raised $38.2M; the latest was Early Stage VC ($30.0M) in Feb 2026.
- Notable investors include Fifty Years, Hummingbird Ventures, Cedars-Sinai Accelerator.
- Status: Privately Held (backing).
HealthLeap's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·Watch HealthLeap: the Monday email on marks, rounds and moves
HealthLeap funding rounds
No funding rounds for HealthLeap are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs HealthLeap
3HealthLeap valuation
HealthLeap's last reported valuation was $206 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
HealthLeap investors
3 investors are on record for HealthLeap, including Fifty Years, Hummingbird Ventures and Cedars-Sinai Accelerator.
About HealthLeap
Developer of an artificial intelligence-driven clinical decision support platform designed for patient risk identification and malnutrition management. The company's platform utilizes machine learning algorithms to conduct continuous, automated analysis of inpatient health data and automated coding assistance for accurate acuity documentation, enabling hospital systems to identify high-risk patients through improved diagnostic accuracy and resource allocation.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 16
- Website
- healthleap.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.